Tennessee House Bill HB1501

Tennessee 2023-2024 Regular Session

• Introduced: 1/31/23
• Refer: 2/2/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to opioids.

Impact

If passed, the bill will necessitate changes in the prescription protocols for healthcare providers prescribing opioids. Specifically, it requires practitioners to have a detailed conversation regarding the risks of addiction, the necessity of the prescription, and the availability of alternative treatments around the time of prescribing an initial dosage or upon a third prescription in a treatment plan. This aims to reduce reliance on opioids and improve patient outcomes through better-informed choices.

Summary

House Bill 1501 aims to amend the Tennessee Code Annotated concerning the prescription of Schedule II controlled substances and other opioid pain relievers. The core objective of the bill is to enhance patient awareness about the risks associated with opioids, mandating healthcare practitioners to engage in meaningful discussions with patients before initiating or continuing a prescription for these medications. This requirement is particularly designed to address the growing opioid crisis by ensuring that patients are fully informed of potential dangers, including addiction and overdose risks, as well as alternative treatment options.

Contention

There may be concerns regarding how HB1501 impacts the ease of access to necessary pain medication for patients who genuinely require it. Critics may argue that while increasing awareness about opioid risks is important, additional requirements on healthcare providers could complicate or delay treatments for patients suffering from acute or chronic pain. Furthermore, exemptions provided for patients currently undergoing treatment for cancer or receiving hospice care might lead to discussions about the adequacy of protection for other vulnerable patient groups, highlighting a potential gap in the bill's coverage.